查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451545

2024-2032 年按治疗类型、药物类别、配销通路和地区分類的失眠市场报告

Insomnia Market Report by Therapy Type, Drug Class, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年全球失眠市场规模达52亿美元。展望未来， IMARC Group预计到2032年市场规模将达到66亿美元，2024-2032年复合年增长率（CAGR）为2.69%。

失眠是一种睡眠障碍，会降低能量水平并影响个人的情绪、健康、工作表现和整体生活品质。其常见原因包括压力、长途旅行、繁忙的工作日程、不良的睡眠习惯、暴饮暴食以及过量摄取尼古丁、咖啡因和酒精。它也可能与心理健康障碍有关，例如创伤后压力症候群，以及使用治疗气喘或血压的抗忧郁药物以及缓解疼痛、过敏和感冒的非处方药 (OTC) 等药物。其治疗方案，例如认知行为疗法（CBT）、非处方睡眠辅助药物以及右佐匹克隆和雷美替胺等处方药，目前在全球范围内可用。

失眠市场趋势：

冠状病毒病 (COVID-19) 大流行为生活带来了前所未有的变化，包括社会隔离以及无数的工作挑战和家庭义务。这是一个重大的压力事件，影响了数百万人的睡眠模式并加强了市场的成长。此外，慢性疼痛、癌症、糖尿病、心臟病、气喘、胃食道逆流（GERD）、甲状腺功能亢进、帕金森氏症和阿兹海默症等疾病通常与失眠有关。因此，患有这些疾病的人数不断增加，推动了对失眠药物的需求。除此之外，月经週期和更年期期间的荷尔蒙变化可能导致失眠的风险，这有助于市场成长。此外，由于睡眠模式、活动和健康的变化以及处方药使用的增加会增加老年人失眠的机会，全球不断增长的老年人口正在催化对失眠医疗的需求。此外，增加对测试新疗法、干预措施和预防、检测、治疗和管理失眠的测试的投资预计将推动市场发展。

本报告回答的关键问题

  • 2023年全球失眠市场规模有多大？
  • 2024-2032年全球失眠市场的预期成长率是多少？
  • 推动全球失眠市场的关键因素是什么？
  • COVID-19 对全球失眠市场有何影响？
  • 根据治疗类型，全球失眠市场的细分情况如何？
  • 根据药物类别，全球失眠市场的细分如何？
  • 全球失眠市场的重点地区有哪些？
  • 谁是全球失眠市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球失眠市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依治疗类型

  • 非药物治疗
    • 市场走向
    • 关键环节
      • 催眠疗法
      • 认知行为疗法
      • 医疗设备
      • 其他的
    • 市场预测
  • 药物治疗
    • 市场走向
    • 关键环节
      • 处方助眠药
      • 非处方助眠药
    • 市场预测

第 7 章：市场区隔：依药物类别

  • 抗忧郁药
    • 市场走向
    • 市场预测
  • 褪黑素拮抗剂
    • 市场走向
    • 市场预测
  • 苯二氮平类
    • 市场走向
    • 市场预测
  • 非苯二氮平类药物
    • 市场走向
    • 市场预测
  • 食慾素拮抗剂
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Astellas Pharma Inc.
    • Aurobindo Pharma Limited
    • Biocodex
    • Eisai Co. Ltd.
    • Mallinckrodt Pharmaceuticals
    • Merck & Co. Inc.
    • Neurim Pharmaceuticals Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
    • Takeda Pharmaceutical Company Limited
    • Vanda Pharmaceuticals Inc.
Product Code: SR112024A6148

The global insomnia market size reached US$ 5.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 2.69% during 2024-2032.

Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.

Insomnia Market Trends:

The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global insomnia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapy type, drug class and distribution channel.

Breakup by Therapy Type:

Non-Pharmacological Therapy

Hypnotherapy

Cognitive Behavioral Therapy

Medical Devices

Others

Pharmacological Therapy

Prescription Sleep Aids

Over-The-Counter Sleep Aids

Breakup by Drug Class:

Antidepressants

Melatonin Antagonist

Benzodiazepines

Nonbenzodiazepines

Orexin Antagonist

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global insomnia market in 2023?
  • 2. What is the expected growth rate of the global insomnia market during 2024-2032?
  • 3. What are the key factors driving the global insomnia market?
  • 4. What has been the impact of COVID-19 on the global insomnia market?
  • 5. What is the breakup of the global insomnia market based on the therapy type?
  • 6. What is the breakup of the global insomnia market based on the drug class?
  • 7. What are the key regions in the global insomnia market?
  • 8. Who are the key players/companies in the global insomnia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Insomnia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapy Type

  • 6.1 Non-Pharmacological Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Hypnotherapy
      • 6.1.2.2 Cognitive Behavioral Therapy
      • 6.1.2.3 Medical Devices
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Pharmacological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Prescription Sleep Aids
      • 6.2.2.2 Over-The-Counter Sleep Aids
    • 6.2.3 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Antidepressants
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Melatonin Antagonist
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Benzodiazepines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Nonbenzodiazepines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Orexin Antagonist
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Pharmacies
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Astellas Pharma Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aurobindo Pharma Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Biocodex
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eisai Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Mallinckrodt Pharmaceuticals
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Neurim Pharmaceuticals Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Takeda Pharmaceutical Company Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vanda Pharmaceuticals Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Insomnia Market: Major Drivers and Challenges
  • Figure 2: Global: Insomnia Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2023
  • Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2023
  • Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Insomnia Industry: SWOT Analysis
  • Figure 82: Global: Insomnia Industry: Value Chain Analysis
  • Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Insomnia Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
  • Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Insomnia Market: Competitive Structure
  • Table 7: Global: Insomnia Market: Key Players